SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-007848
Filing Date
2024-02-26
Accepted
2024-02-26 17:15:23
Documents
16
Period of Report
2024-02-22
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 55243
2 ex3-1.htm EX-3.1 12104
  Complete submission text file 0001493152-24-007848.txt   293239

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE celu-20240222.xsd EX-101.SCH 3872
4 XBRL DEFINITION FILE celu-20240222_def.xml EX-101.DEF 26769
5 XBRL LABEL FILE celu-20240222_lab.xml EX-101.LAB 37009
6 XBRL PRESENTATION FILE celu-20240222_pre.xml EX-101.PRE 25393
17 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 6029
Mailing Address 170 PARK AVE FLORHAM PARK NJ 07932
Business Address 170 PARK AVE FLORHAM PARK NJ 07932 (908) 768-2170
Celularity Inc (Filer) CIK: 0001752828 (see all company filings)

IRS No.: 831702591 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38914 | Film No.: 24680148
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)